Found: 75
Select item for more details and to access through your institution.
Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
- Published in:
- Scientific Reports, 2015, p. 16129, doi. 10.1038/srep16129
- By:
- Publication type:
- Article
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 9, p. 1592, doi. 10.7150/jca.83853
- By:
- Publication type:
- Article
Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00934-z
- By:
- Publication type:
- Article
Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 3, p. 1, doi. 10.1038/s41419-023-05709-z
- By:
- Publication type:
- Article
Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04550-0
- By:
- Publication type:
- Article
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03641-8
- By:
- Publication type:
- Article
Ultrasound features of medullary thyroid cancer as predictors of biological behavior.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tumor Biology is King: Secondary Tumors of the Thyroid From 2 Medical Centers in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tumor Biology is King: Secondary Tumors of the Thyroid From 2 Medical Centers in China.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 3, p. 1, doi. 10.1177/1073274820945984
- By:
- Publication type:
- Article
Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2023.1251820
- By:
- Publication type:
- Article
Tuning Metal‐Support Interaction and Surface Acidic Sites of Ni/Al<sub>2</sub>O<sub>3</sub> by Dopamine Modification for Glycerol Steam Reforming.
- Published in:
- ChemCatChem, 2022, v. 14, n. 1, p. 1, doi. 10.1002/cctc.202101150
- By:
- Publication type:
- Article
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1224828
- By:
- Publication type:
- Article
Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231189429
- By:
- Publication type:
- Article
Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221119318
- By:
- Publication type:
- Article
Genetic and clinical characteristics of head and neck paragangliomas in a chinese population.
- Published in:
- Laryngoscope, 2012, v. 122, n. 8, p. 1761, doi. 10.1002/lary.23360
- By:
- Publication type:
- Article
Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03397-3
- By:
- Publication type:
- Article
Visual Interpretability in Computer-Assisted Diagnosis of Thyroid Nodules Using Ultrasound Images.
- Published in:
- Medical Science Monitor, 2020, v. 26, p. 1, doi. 10.12659/MSM.927007
- By:
- Publication type:
- Article
Ensemble Deep Learning Model for Multicenter Classification of Thyroid Nodules on Ultrasound Images.
- Published in:
- Medical Science Monitor, 2020, v. 26, p. 1, doi. 10.12659/MSM.926096
- By:
- Publication type:
- Article
Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6670, doi. 10.3892/ol.2019.11059
- By:
- Publication type:
- Article
Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer.
- Published in:
- Oncology Letters, 2019, v. 17, n. 5, p. 4661
- By:
- Publication type:
- Article
EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines.
- Published in:
- Oncology Letters, 2018, v. 15, n. 5, p. 6763, doi. 10.3892/ol.2018.8093
- By:
- Publication type:
- Article
Integrated microRNA‑mRNA analyses of distinct expression profiles in follicular thyroid tumors.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7153, doi. 10.3892/ol.2017.7146
- By:
- Publication type:
- Article
Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAF<sup>V600E</sup>‐associated thyroid carcinoma.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1694
- By:
- Publication type:
- Article
Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.896121
- By:
- Publication type:
- Article
Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.920857
- By:
- Publication type:
- Article
Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.
- Published in:
- Bioscience Reports, 2020, v. 40, n. 10, p. 1, doi. 10.1042/BSR20202544
- By:
- Publication type:
- Article
Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing tsMHCII-mediated Immune Recognition.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 59, doi. 10.1007/s10147-019-01522-x
- By:
- Publication type:
- Article
Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 59, doi. 10.1007/s10147-017-1170-6
- By:
- Publication type:
- Article
Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1216394
- By:
- Publication type:
- Article
Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower <sup>131</sup>i uptake in metastases.
- Published in:
- IUBMB Life, 2019, v. 71, n. 7, p. 1030, doi. 10.1002/iub.2056
- By:
- Publication type:
- Article
Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3239, doi. 10.1002/cncr.34897
- By:
- Publication type:
- Article
The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
- Published in:
- Clinical Otolaryngology, 2023, v. 48, n. 5, p. 734, doi. 10.1111/coa.14053
- By:
- Publication type:
- Article
BRAF<sup>V600E</sup> status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 104, doi. 10.1186/1477-7819-10-104
- By:
- Publication type:
- Article
Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.
- Published in:
- Endocrine (1355008X), 2021, v. 74, n. 1, p. 108, doi. 10.1007/s12020-021-02717-x
- By:
- Publication type:
- Article
Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
- Published in:
- Langenbeck's Archives of Surgery, 2024, v. 409, n. 1, p. 1, doi. 10.1007/s00423-024-03431-8
- By:
- Publication type:
- Article
Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15025
- By:
- Publication type:
- Article
Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.9675
- By:
- Publication type:
- Article
Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29000-5
- By:
- Publication type:
- Article
Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1008301
- By:
- Publication type:
- Article
Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway.
- Published in:
- International Journal of General Medicine, 2023, v. 16, p. 5651, doi. 10.2147/IJGM.S442937
- By:
- Publication type:
- Article
PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 12, p. 3970, doi. 10.7150/ijbs.81895
- By:
- Publication type:
- Article
Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00217
- By:
- Publication type:
- Article
Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression.
- Published in:
- Medical Oncology, 2024, v. 41, n. 6, p. 1, doi. 10.1007/s12032-024-02380-y
- By:
- Publication type:
- Article
Author Correction: Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48173-9
- By:
- Publication type:
- Article
Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAF Mutational Status of 977 Cases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 7, p. 2266, doi. 10.1245/s10434-012-2851-z
- By:
- Publication type:
- Article
An Inducible CRISPR‐dCas9‐Based Transcriptional Repression System for Cancer Therapy.
- Published in:
- Small Methods, 2024, v. 8, n. 8, p. 1, doi. 10.1002/smtd.202301310
- By:
- Publication type:
- Article